Elixir Chooses Maxor Specialty as CF Medication Provider

Elixir Chooses Maxor Specialty as CF Medication Provider

307862

Elixir Chooses Maxor Specialty as CF Medication Provider

Pharmacy benefits and services company Elixir has chosen Maxor Specialty Pharmacy to be its network’s exclusive provider of medications for cystic fibrosis (CF). Maxor Specialty specializes in rare diseases like CF and is one of four pharmacies in the U.S. to have access to all medications approved for cystic fibrosis, including the triple combination therapy Trikafta, as well as Kalydeco, Orkambi, and Symdeko An Elixir’s specialty pharmacy provides continuous support, treatment, and care in a form tailored to suit the particular needs…

You must be logged in to read/download the full post.